AbbVie has agreed to acquire Gilgamesh Pharmaceuticals’ lead pipeline asset bretisilocin, a clinical-stage candidate designed to treat moderate-to-severe major depressive…
One distinction between natural photochemistry and artificial photosynthesis is the number of electrons transferred at the same time—the latter relies…